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ABSTRACT
Enteroviruses, specifically of the Coxsackie B virus family, have been implicated 
in triggering islet autoimmunity and type 1 diabetes, but their presence in pancreata 
of patients with diabetes has not been fully confirmed. 
To detect the presence of very low copies of the virus genome in tissue samples 
from T1D patients, we designed a panel of fluorescently labeled oligonucleotide 
probes, each of 17-22 nucleotides in length with a unique sequence to specifically 
bind to the enteroviral genome of the picornaviridae family. 
With these probes enteroviral RNA was detected with high sensitivity and 
specificity in infected cells and tissues, including in FFPE pancreas sections from 
patients with T1D. Detection was not impeded by variations in sample processing and 
storage thereby overcoming the potential limitations of fragmented RNA. Co-staining 
of small RNA probes in parallel with classical immunstaining enabled virus detection 
in a cell-specific manner and more sensitively than by viral protein.
INTRODUCTION
Type 1 diabetes (T1D) is a chronic multifaceted 
disorder that results from selective autoimmune-
mediated destruction of the insulin producing β-cells. 
Environmental factors [1], together with genetic 
predisposition [2], interact cooperatively to initiate chronic 
islet autoimmunity [3]. 
Viruses have been proposed as possible initiators of 
islet autoimmunity and were first implicated as long ago 
as the nineteenth century although it was not until much 
later that a clear association was established between 
mumps and diabetes [4-6]. Improvements in molecular 
biology subsequently broadened the panel of viruses 
which are implicated in causing diabetes [7, 8] and the 
weight of evidence now suggests that coxsackieviruses [9] 
play a role. In support of this, a clear correlation between 
enterovirus infection and the onset of T1D was revealed 
in association studies [10] and via a comprehensive meta-
analysis [11].
Coxsackieviruses belong to the Picornaviridiae, 
and are small positive-sense single stranded RNA viruses, 
which have been shown recently to induce a persistent, 
slowly-replicating infection in both myocardium and 
pancreas. This may result from alteration to the viral 
genome during the progress of infection including 
the generation of naturally occurring 5’-deletions 
[12-14]. Several direct (immunohistochemistry) and 
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indirect (serology, isolation of viruses from patients) 
approaches have confirmed the presence of enterovirus 
both in the circulation and in the islets of T1D patients 
[15-20]. Enteroviruses in the pancreas were detected 
by immunostaining for viral protein (VP1) [17, 21], 
which is highly expressed under acute viral infection 
and diminishes in persistent infection and may not be 
detected under circumstances where viral replication 
is compromised [22]. Also, non-specific interaction of 
the VP1 antibody with other cellular proteins has been 
reported [23, 24].
A well-characterized cohort of human pancreatic 
donor tissue has been established by nPOD (Network for 
Pancreatic Organ Donors with Diabetes) and is available, 
similar to other cohorts, mainly as formalin fixed, 
paraffin embedded samples (FFPE) [25]. This method 
ensures preservation of the samples for many years, but a 
limiting factor is the relatively poor RNA integrity often 
associated with FFPE preservation which means that 
analysis of tissue samples by PCR can be difficult [26]. 
Also, detection of the viral genome in the pancreas has 
been challenging and more sensitive and reliable methods 
are required. 
This has created pressure to develop alternative 
(accurate and equally sensitive) methods to allow the 
detection of RNA in single cells within FFPE tissue 
samples. An obvious candidate is in situ hybridization, 
where labeled oligonucleotide probes specifically pair 
with target nucleic acids via Watson-Crick base pairing 
and some success has been gained using long probes 
(~50-100nts) labeled with either radioisotopes or enzymes 
catalyzing chromogenic reactions. However, this approach 
also has limitations in the face of samples with poor RNA 
integrity or very low target RNA copy numbers. Thus, 
improved RNA FISH methods have been developed to 
overcome these hurdles. Enteroviral RNA was detected by 
a new generation of RNA probes (QuantiGene® ViewRNA 
Assay), which depend on signal amplification [25]. This 
approach offers the advantage of signal amplification via 
the use of branched secondary probes but, theoretically, 
may be affected by several conditions. To create a 
docking site for the branched probes, two probes must sit 
adjacent to one-another on the target sequence, effectively 
lengthening the de facto short probes. However, RNA 
degradation can still affect the docking of probes and 
hence signal enhancement. Flexibility in choosing the 
binding site with the best thermodynamic characteristics 
may also be compromised.
Because of such limitations to the detection of 
enteroviruses with high accuracy and sensitivity, we 
present here an adapted method to target single RNA 
molecules with short (~20nts) fluorescently labeled 
oligonucleotides in situ. These oligonucleotides anneal 
to common regions of the RNA genome of members of 
the coxsackievirus family. Such short singly labeled oligo 
RNA probes are resistant to RNAse and RNA detection 
is less affected by target RNA degradation, making these 
probes more versatile while retaining sensitivity and 
specificity. Because their binding to the target sequences 
occurs independently for each probe, this gives probe 
combinations the advantage that there is a degree of 
freedom in their positioning without risk of the loss of 
stringency, efficiency or specificity. 
To generate a distinct fluorescent signal above 
background noise, a sufficient amount of labeled probes 
must bind in close proximity [27-29], thereby ensuring 
high specificity and considerable flexibility of detection 
after hybridisation. The use of small contiguous RNA 
species also overcomes the potential limitation of 
fragmented target RNA. With our newly established 
protocol, we successfully detect viral RNA in both cell 
culture and FFPE tissue sections, in combination with 
classical immunostaining. Short probes were able to 
detect viral infection at lower viral loads than classical 
immunostaining and the method is comparable in 
sensitivity to that of semi-nested PCR [30].
RESULTS
An established protocol for short RNA-oligoprobe 
labeling in FFPE tissue sections
In order to develop a robust protocol for RNA-
oligoprobe labeling of FFPE pancreatic tissue sections, 
we initially tested a commercially available probe set 
targeting the housekeeping gene (GAPDH) in cultured 
HEK293 cells and in isolated FFPE human islets (Figure 
1). Natural, as well as fixative-derived signal noise, is a 
major problem when employing fluorescence microscopy 
to detect probes targeting RNA molecules, especially 
when these are present in low abundance. Thus, while 
our test probes gave a very specific signal in cultured 
HEK293 cells (Figure 1A), probing of FFPE human islets 
generated high background noise both in the absence of 
probes (Figure 1B) and with the GAPDH probes (Figure 
1C), when following the standard protocol. Reduction 
in the FFPE-derived background signal was achieved 
by the removal of any remaining paraffin wax crystals 
(see material and methods). This involved the use of a 
protocol in which xylene washes were undertaken at 
high temperatures prior to a step utilizing pepsin/HCl to 
separate proteins from nucleic acids. In addition, Sudan 
black was included to reduce the overall FFPE-derived 
background fluorescence. Using this modified protocol, 
single positive dots (representing hybridization to as few 
as one RNA molecule) could be detected within the Abbe-
diffraction limit and were easily discriminated from any 
residual background noise (Figure 1D). 
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Figure 1: An established protocol for short RNA-oligoprobe labeling in FFPE tissue sections. A. GAPDH oligonucleotides 
were tested in the cell line HEK 293. Single fluorescent spots, each representing one single RNA molecule, are clearly visible. B. Normal 
deparaffinization procedure shows high background noise in FFPE islet sections even without probes (No Probes) and does not allow 
clear distinction of probe signal and background, when GAPDH oligonucleotides were added C.; Standard Protocol. Modification of the 
deparaffinization and post-hybridisation protocol leads to background reduction and increased signal intensity of GAPDH oligonucleotides 
D.; Modified Protocol. RNA Probes are labeled with Quasar 570 (red) and nuclei were stained with DAPI (blue), scale bar depicts 10µm.
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RNA-oligonucleotide probe design and specificity
Probe set CVB_1 included a wide range of group 
B coxsackieviruses; it consisted of a mixture of 40 short 
oligonucleotides, each comprising 17-22 nucleotides 
covering the whole viral genome (see material and 
methods and Figure 2A). This enabled us to target single 
RNA molecules. To detect a positive signal, it was 
determined that at least 17 of the probes in a given set 
must bind to their target sequence with only one mismatch 
allowed with respect to the stringency parameters [25]. 
To test the specificity of the probe set CVB_1, 
HEK293 cells were fixed and processed after either 
culture without viruses or following infection with 
coxsackieviruses CVB3 and CVB2 (Figure 2B) which 
share a sequence similarity of about 79%. Cells were 
infected for 2h at an MOI of 5 and the viruses allowed 
to replicate for 24h prior to fixation and analysis. Probes 
efficiently detected viral genomes within infected cells 
(Figure 2B, CVB3 and CVB2) whereas signal was 
absent from uninfected cells (Figure 2B, non-infected), 
confirming that the virus-specific probe set had no off-
target effects. 
The specificity of the probe set was further tested in 
HEK293 cells infected with cytomegalovirus (CMV), a 
DNA virus of the herpesviridae family (Figure 2B, CMV) 
or hepatitis A virus (HAV), a positive ssRNA virus of 
the picornaviridae family (Figure 2B, HAV). Following 
infection at an MOI of 5 and incubation for 4 days to 
ensure viral replication, there was no visible cytopathic 
effect. The presence of virus was confirmed by RT-PCR 
(Suppl.Figure 1A). CMV appeared not to be in an active 
phase of replication as no signal was generated by RT-
PCR of DNAse-treated samples. In neither HAV nor CMV 
infected cells were probe-specific hybridization spots 
detected, confirming the probe specificity. HAV shares 
partial sequence similarity with CVB3 (<45%) while 
CMV is a DNA virus; for each, the number of “on target” 
probes was below the detection limit of the assay. 
The likelihood that the signals detected in samples 
were non-specific was further excluded by staining CVB3 
infected islets in the absence of the probe set and by 
staining uninfected cells with the probe set. In each case, 
the negative controls delivered no staining, whereas virally 
infected cells yielded positive signals (Suppl.Figure 1B). 
RNAse A treatment abolished the signal from infected 
cells and confirmed that the probe set is specific to viral 
RNA (Suppl.Figure 1B). 
We further tested the CVB_1 probe set on an array 
of cell lines previously generated for use with Quantigene® 
ViewRNA virus probes [21]. Green monkey kidney cells 
(GMK and Vero), the human cervix (HeLa), alveolar 
(A549) epithelial carcinomic and rhabdomyosarcoma 
(RD) muscle cells were infected with viruses from the 
enterovirus groups A and B or adenovirus (DNA virus) 
[21] (Table 1 and Suppl.Figure 2). In line with the results 
obtained with Quantigene® ViewRNA by Laiho et al. [21] 
the CVB_1 probe set yielded positive staining for viruses 
of both groups A and B, while it did not stain cells infected 
with adenovirus and human parechovirus 1 (HPeV1) (0/ 40 
probes binding). Also, there was no binding to sequences 
from coxsackievirus A5 (11/40 probes theoretically match 
the virus sequence). 
Table 1: RNA oligonucleotide staining of different picornaviridae and control viruses
Virus Strain Result Virus Strain Result
EV71 PB-EV71Hus ++ Echo3 PB-E3DiT23 ++
CVB1 ATCC ++ Echo4 ATCC ++
CVB2 ATCC ++ Echo6 ATCC +
CVB3 ATCC ++ Echo9 ATCC +
CVB4 ATCC ++ Echo11 ATCC +
CVB5 ATCC ++ Echo30 ATCC ++
CVB6 ATCC ++ PV3 Sabin +
CVA2 PB-CVA2V38 ++ HPeV1 ATCC -
CVA4 PB-CVA4V36 ++ Adenovirus C VR846 -
CVA5 PB-CVA5V43 - A549 cells - -
CVA6 PB-CVA6V303V + RD cells - -
CVA9 ATCC ++ Vero cells - -
CVA10 PB-CVA10V2530 ++ HeLa cells - -
CVA16 PB-CVA16V55 ++ GMK cells - -
Probe specificity was tested on a cell array (FFPE); different cell lines were spotted either as uninfected controls or infected 
with different viruses. The results obtained with RNA probes set CVB_1 are displayed. Representative images are shown in 
Fig. S2.
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Figure 2: RNA-oligonucleotide probe design and specificity. A. Scheme of custom-designed oligonucleotide (CVB_1) annealing 
throughout the viral genome. B. Viral RNA probes were tested against non-infected, CVB3 and CVB2 (100% and 79% similarity to 
consensus sequence, respectively; positive control), CMV, (DNA virus; negative control) and HAV (<45% similarity to consensus sequence) 
infected HEK 293 cells. Cells were infected with an MOI of 5 and harvested after 24h (control, CVB3, CVB2) or 4 days (CMV, HAV) post-
infection. RNA Probes are labeled with Quasar 570 (red) and nuclei were stained with DAPI (blue), scale bar depicts 10µm.
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RNA-oligonucleotide probe sensitivity and 
consistency
Next, we evaluated sensitivity of the CVB_1 probe 
set. Our RNA-FISH system was compared with two of the 
most widely used and well established techniques for virus 
detection: RT-PCR and immunohistochemistry using an 
antibody against the viral capsid protein 1 (VP1). RT-PCR 
is the most powerful and specific tool for RNA detection; 
but RNA accessibility and degradation are two important 
limiting factors. To compare the sensitivity of the RNA 
probes with analysis by PCR, the pancreatic line CM9 
[31] and HEK293 cells were infected with CVB3. Since 
both RT-PCR and RNA-FISH can, in principle, detect the 
presence of a single RNA molecule, we used successive 
10-fold serial dilutions of virus prior to infection of cells 
and to compare the sensitivity of the methods. Cells 
were plated in duplicates and the virus (CVB3; starting 
MOI of 100) was centrifugally inoculated at 16°C for 
1h to synchronize the infection. After inoculation, any 
unbound viruses were removed by washing and the cells 
incubated at 37°C for an additional hour, to allow virus 
internalization and genome release from the capsid, before 
fixation or cell lysis for RNA extraction. Both RNA-FISH 
(Figure 3A, 3B and Suppl.Table 1) and RT-PCR (Figure 
3C and Suppl.Table 2) were able to detect the presence of 
viral genomes, even at the highest dilution (10-8) (Figure 
3B, 3C). Using RNA-FISH probes, single RNA molecules 
were detected and a plateau reached at a dilution of 10-3 
virus by both visual counting and RT-PCR (Figure 3B-3C). 
The specificity of the RT-PCR results were confirmed by 
examination of dissociation curves, which were identical 
in all cases while samples from non-infected cells showed 
no signal (data not shown). 
We next compared the efficiency of the CVB_1 
probe set with the widely used VP1 (clone 5-D8/1, Dako 
cytomations) antibody, using a cell array of the human 
alveolar basal epithelial cell line A549 infected with CVB1 
for 2, 4 and 6 h to generate a population representing 
different stages of infection [27]. After infection, cells 
were serially diluted with uninfected A549 cells to achieve 
a range from undiluted to 10-8. The cells were then fixed 
and paraffin embedded. When employed at a dilution 
of 1:2000 (which ensures specificity and minimizes the 
possibility of false positives [23, 24]), the VP1 antibody 
yielded positive signals only at dilutions of 10-1 or lower, 
whereas the RNA-FISH probes were able to detect viral 
RNA even at the highest dilution of 10-8 (Figure 3D, 3E). 
The design of the RNA-FISH system should 
circumvent the problem of RNA degradation since it 
employs multiple probes to detect the target RNA. RNA 
fragmentation frequently occurs in, for example, autopsy 
samples, where processing and storage under RNAse free 
conditions is unlikely. We therefore tested FFPE CVB1-
infected GMK cell sections, which had been infected and 
processed at the same time, but then cut and processed 
at different times (covering periods between 2012 and 
2015) and stored at room temperature. The probes 
showed similar signals in all three samples regardless of 
the processing and storage time. Importantly, uninfected 
controls were negative (Suppl.Figure 3).
Coupling RNA-FISH and immunohistochemistry
Important advantages of the use of RNA-
FISH probes relate not only to their high sensitivity 
and specificity but also their ability to localize RNA 
molecules within specific cells of tissues such as the 
pancreas. We, therefore, investigated the localization and 
distribution of the signal emanating from the viral probes 
within the pancreas and compared this with detection 
by immunohistochemistry with the widely used VP1 
antibody. 
Figure 4A shows a schematic representation of 
the expected profile of virus-staining: RNA probes (red) 
are not expected to anneal to the viral RNA while it is 
packaged within the capsid. However, once released 
within the cell, the probes should bind. Conversely, 
the VP1 antibody (green) should always bind to the 
capsid surface or, conceivably, to free VP1 which has 
not been incorporated into capsids. To visualize any 
differential labeling, human CM9 cells were infected 
with centrifugally inoculated CVB3 at an MOI of 1000. 
(Figure 4B). Anti-VP1 was detected at the plasma 
membrane and in the cytoplasm while RNA probes were 
localized exclusively in the cytoplasmic area (Figure 4B, 
middle panel and Suppl.Figure 4 for enhanced signals). 
As depicted at larger magnification, signals from the RNA 
molecules co-localized, or were in close proximity with 
those arising from the capsid protein, but the two were 
not superimposed. To verify the staining patterns, we 
also performed VP1 immunohistochemistry prior to cell 
permeabilization and subsequent RNA-FISH, so that the 
signals should not co-localize. As shown in Figure 4B 
(right panel), under these conditions the signals arising 
from each method of detection were clearly separate. 
Uninfected CM9 cells were used as controls and showed 
no nonspecific signal for either anti-VP1 or the RNA-
probes (Figure 4B).
Successful double staining of viral RNA and VP1 
was confirmed in FFPE infected mouse spleen. Spleen 
sections from mice infected with CVB1 were stained 
with the CV_1 probe set to detect the viral genome and 
subsequently with anti-VP1 in an additional round of 
staining of the same section. Both techniques showed 
positive staining within the same regions of the samples 
(Suppl.Figure 5A).
Double staining of FFPE CVB3 infected cultured 
rat INS1-E cells for insulin and virus probes showed co-
localization of viral RNA within insulin positive INS-
1E cells (Figure 4C). Close proximity of viral RNA and 
insulin was also found in a Coxsackie infected neonatal 
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Figure 3: RNA-oligonucleotide probe sensitivity. A. CM 9 and HEK 293 were infected with a dilution series (MOI 102-10-8) of 
CVB3 and stained with custom-designed oligonucleotides (CVB_1). Representative images of CM9 and HEK293 cells infected with 
either the highest or lowest dilution of CVB3 of the series are shown. White arrows highlight single viral spots. B. Ten single images were 
acquired for each dilution and single fluorescent spots were manually counted. Results for HEK 293 (diamonds) and CM 9 (squares) are 
displayed as single spots per cell in logarithmic scale. In total, viral particles were counted in 4470 HEK293 cells and CM9 cells. C. Viral 
RNA from a parallel experiment was extracted and analyzed by PCR; MOI of 100 (102) was set as 100%. D. Viral RNA (red) and VP1 
(1/2000; green) staining on a CVB1-dilution array of FFPE infected GMK cells mixed with uninfected cells. RNA Probes were labeled 
with Quasar 570 (red) and nuclei were stained with DAPI (blue), scale bar depicts 10µm. E. Summary of the viral RNA and VP1 signals 
obtained from a CVB1-dilution array of FFPE infected GMK cells. 
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Figure 4: Coupling RNA-FISH and Immunohistochemistry. A. Theoretical scheme of viral RNA and VP1 co-staining. Initially, 
labeled oligonucleotides cannot bind viral RNA within the capsid, but only when the virus is released. On the other hand, VP1 antibody can 
bind to the capsid surface. Over time as more RNA is released, more probes can anneal to their target sequence. When a sufficient amount 
of oligonucleotides is bound, green (VP1) and red (RNA) signal are visible in close proximity. B. CM9 cells were infected with CVB3 
(MOI 1000) for 1h at 16°C, fixed and probed for viral RNA and VP1. VP1 (green) was found in close proximity with viral RNA (red), 
when capsid and RNA were present in the cytosol area (B; middle panel). When VP1 staining was performed before cell permeabilization 
no colocalization of viral RNA/VP1 was detected (B; right panel). No cross-reactivity was found with cellular proteins or RNAs (B; left 
panel). C. Co-staining and localization of viral RNA (red) and insulin (green) in CVB3-infected INS-1E cells and HgCl2 fixed paraffin 
embedded CVB-infected neonatal pancreas. Samples were stained with RNA FISH probes first, analyzed and then stained for insulin. 
The non-granular insulin staining in this slide appeared also by classical single insulin immunohistochemistry and is caused by the tissue 
condition. Nuclei were visualized by DAPI staining (blue); scale bar depicts 10µm.
Oncotarget9www.impactjournals.com/oncotarget
mouse pancreas (Figure 4C), confirming the established 
double-staining protocol also in HgCl2 fixed and paraffin 
embedded cells. To demonstrate efficacy for virus staining 
in various tissues, we stained a section from a coxsackie-
infected neonatal heart and found cells displaying a strong 
signal corresponding to viral RNA (Suppl.Figure 5B). 
Viral RNA localization in the pancreas in T1D
Having established the validity of our approach, 
we then used an enterovirus genome alignment (Suppl.
Figure 6) to design two additional probe sets (CVB_2 and 
CVB_3; Suppl.Tables 4,5), which would complement the 
first set and allow detection of the entire range of group 
B enteroviruses. A scheme of the binding positions of the 
newly designed probe sets is shown in Figure 5A. We then 
used a combination of the three probe sets for a blinded 
analysis of autopsy pancreatic tissue recovered from 
nondiabetic and T1D patients having remaining residual 
β-cells from a UK cohort [31, 32]. As shown in Table 
2, we were able to detect the presence of enteroviruses 
in 7 of 8 pancreas samples from T1D patients and in 2 
of 8 nondiabetic controls. While viral RNA was found 
within the insulin-positive islet area in 6 of 8 T1D patients 
(Table 2 and Figure 5B), 5 of 8 pancreata also yielded 
positive signals for enteroviral RNA in the exocrine area. 
A single T1D patient from the UK collection had viral 
RNA exclusively in the exocrine area of the pancreas 
and not in the islets (although in this patient, only 1 
fragmented and 2 normal islets were found throughout the 
whole section). Similarly, this distribution of viral RNA 
was also observed in a pancreas transplant biopsy from 
a patient with T1D who had developed recurrent disease 
from the nPOD-Transplantation cohort [32] (Figure 5C). 
In one nondiabetic control, we also found viral RNA in 
islets. Comparison of our results with anti-VP1 staining 
on the same samples performed separately in Exeter, 66% 
concordance was achieved. Thus, while virus was detected 
using viral probes in 6 out of 8 T1D pancreata within the 
insulin-positive islet area, VP1 staining was present in 
only 4/8 pancreata. 
DISCUSSION
In this study we present a robust method to identify 
and localize enteroviral RNA in FFPE tissue, which was 
established for the analysis of viral infection in pancreata 
from patients with T1D. The use of RNA probes allowed 
the discrimination of virally-encoded RNA from virus 
replication loci with high fidelity and sensitivity. Adapting 
a method from Raj et al. [28, 29], we created a set of short 
fluorescently labeled oligonucleotide probes that anneal to 
common regions of the coxsackievirus family in situ to 
target single RNA molecules. 
Probe sets are easily developed using the online 
Stellaris® RNA FISH Probe Designer. With three different 
sets of probes we were able to localize viral RNA in all 
tested tissue including FFPE tissues from patients with 
proven coxsackievirus infection and in the pancreas of 7 
Table 2: RNA oligonucleotide staining of human pancreases
Sample Group ID Age Sex Fixation Viral RNA +* Islet viral RNA +
VP1+ T1D E560 42 F BF ++++ +
VP1+ T1D 11746 6 M HgCl2 ++ +
VP1+ T1D E375 11 F FS + +
VP1+ T1D E554A 7 M Bouin - § +
VP1 – T1D E428 5 M BF ++ +
VP1 – T1D E514 23 M BF - +
VP1 – T1D E235 6 M HgCl2 - - §
VP1 – T1D 8869 8 M HgCl2 + - §
Non-diabetic control 8579 7 - HgCl2 - -
Non-diabetic control 12054 7 - HgCl2 - -
Non-diabetic control 330/71 47 M BF - -
Non-diabetic control 21/89 4 F BF ++ -
Non-diabetic control 274/91 6 M BF - -
Non-diabetic control 191/67 25 M BF - -
Non-diabetic control 315/89 9 M BF + +
Non-diabetic control 540/91 11 M BF - -
Summary of the comparative study of pancreata from T1D and non-diabetic control patients. Sections were first stained for 
viral RNA, with a combination RNA probe sets CVB_1, CVB_2 and CVB_3, followed by insulin staining. - = less than 10 
fully-infected cells, + = 10 to 30 fully-infected cells, ++ = 30 to 100 fully-infected cells, +++ = 100 to 200 fully-infected cells, 
++++ = more than 200 fully-infected cells in the exocrine. §E554A showed ten fully-infected cells, E235 contained just 5 islets 
on the section and 8869 just 2 full and 1 fragmented islets (very small sections). 
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Figure 5: Viral RNA within an islet of a T1D patient. A. The original probe set CVB_1 was complemented with two additional 
sets (CVB_2 and CVB_3). Scheme of custom-designed probe sets annealing throughout the viral genome. Arrows show localization of 
CVB_1, lines show the positions of CVB_2 and CVB_3 probe sets. B., C. Representative images of donors E375 and E514 form the UK 
cohort and of donor 3626 from the nPOD cohort. Virus RNA was found within the endocrine area (B) and outside the islets (C) shown by 
the co-staining of viral RNA probes (combination of CVB_1, CVB_2 and CVB3) (red) and insulin (Green). Tissues were first probed for 
viral RNA, analyzed and then stained for insulin. Nuclei were visualized by DAPI staining (blue); scale bar depicts 10µm.
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of 8 patients with T1D.
Use of our probe sets with the method described can 
be routinely applied for virus identification in the pancreas 
(and, in principle, in any other tissue). It should also now 
be possible, to increase the specificity of the probe sets for 
particular virus strains in order to specifically characterize 
the infection of pancreatic islets in patients with T1D. 
This is a major undertaking, but is possible using the 
well-preserved and -characterized FFPE tissues available 
within the nPOD initiative.
Although enteroviruses (including members of the 
Coxsackie B virus/ CVB family), have been suspected as 
potential triggers of T1D for a long time, firm evidence of 
viral genome expression in the pancreas has been largely 
elusive.
Most evidence supporting a causative role for 
enteroviral infections in diabetes onset have come from 
epidemiological studies [4-6, 11] or from the identification 
of viral antigens in fixed pancreatic tissue [33, 34]. By 
contrast, there have been few successful attempts to detect 
viral genome, except in isolated islet samples or in a small 
number of samples where positive signals were seen by in 
situ hybridisation. 
For a long time the approach to identify the disease’s 
trigger has been based on the four Koch’s postulates [35], 
which were formulated only considering acute infection 
but are unfitted when the infection has been encountered 
long before manifestation of the disease. From tail 
biopsies of living newly diagnosed T1D patients of the 
DiViD study (3-9 weeks after T1D onset), VP1 was 
detected in the pancreas in all patients in 1.7% of the 
islets. This 100% association of VP1 and T1D could lie 
in the VP1 characteristics, which is highly expressed at 
acute viral infection and diminishes in persistent infection 
[17]. Indirect evidence has been provided to confirm islet 
cell enteroviral infection by the demonstration of human 
leukocyte antigen (HLA) class I expression in all patients. 
In contrast to HLA class I and VP1, viral genome was 
found in less; 4 of 6 patients at very low concentrations 
(by PCR, >40 cycles). Although this was a very small 
study, it was the first showing full correlation of viral RNA 
by at least one method [17] and convinces that a pancreatic 
enterovirus infection occurs before or at the time of T1D 
onset and may be causative for auto-immune activation 
and β-cell destruction. Nevertheless, the DiViD study also, 
suggests no evidence of acute infection, and thus confirms 
earlier studies from the UK and nPOD cohorts pointing at 
chronic, low-grade infection [34].
Several hypotheses have been proposed to explain 
why the viral genome has proven so difficult to detect in 
the islets of patients with T1D [1]: (i) viral infection could 
act as an initial trigger to activate autoimmunity but the 
infection may not sustain for long periods; one or multiple 
viruses can act in concert or in waves leading slowly to 
β-cell failure. (ii) The virus genome may be modified such 
that it becomes persistent with very low copy numbers 
present in infected cells being then difficult to detect [1]. 
In this context, coxsackieviruses have been shown to 
establish persistent infections in human heart [22] and in 
the mouse pancreas [36] via a process involving deletion 
of the 5’-UTR of the viral genome [14], viruses would 
be undetected by classical PCR/VP1 staining approaches. 
Whether this happens in human pancreas has been yet not 
verified.
In the present work, we have overcome these 
difficulties by deploying our highly sensitive FISH 
method to provide evidence that enteroviral genome can 
be detected more frequently in the pancreas of patients 
with T1D than in equivalent controls.
The technique applied in this study combines the 
advantages associated with access to FFPE samples 
(which retain tissue morphology and allow precise 
localization of cellular and tissue structures) with a highly 
sensitive detection method. The sensitivity of detection 
was much greater than that achieved with classical 
immunohistochemistry to detect the viral capsid protein, 
VP1, implying that it is ideal for use in circumstances 
where viral replication may be compromised [36]. 
To verify these conclusions, we compared directly 
results obtained by RNA-FISH with those employing a 
widely used anti-VP1 (clone 5-D8/1) antibody in infected 
FFPE material. We carefully established optimized 
conditions for specific virus detection to avoid interactions 
of VP1 antibody with other cellular proteins. As a result, 
we were able to identify viral RNA with much greater 
sensitivity such that a single RNA molecule was labelled. 
The use of other sensitive techniques, which might match 
the sensitivity achieved here (such as PCR, either direct 
or nested), is limited because of the low accessibility and 
stability of nucleic acids [26]. By contrast, improvements 
in in situ hybridization (ISH) and fluorescent in situ 
hybridization (FISH) have increased both the sensitivity 
and specificity of RNA detection such that they now 
represent a valid alternative to PCR, with the advantage 
that they can spatially localize particular RNA molecules 
within fixed cells [25].
The unique advantage of the small contiguous 
probe sets presented in this study is that RNA duplexes 
are detected via microscopy, because of direct conjugation 
of fluorophores to the probe [29]. In order to obtain a 
detectable signal, multiple probes must then bind to their 
target RNA to allow the close apposition of sufficient 
fluorophores for detection under the microscope. A key 
advantage of this approach is that the potential “off-target” 
binding of a few oligonucleotides from the probe pool 
will be either undetectable or where it is detected, can be 
readily distinguished from the much brighter spots that 
correspond to the true targets. A minimum of 17 out of 40 
probes must bind in order to generate a specific signal in 
accordance with the Abbe diffraction limit [29].
A significant problem in fluorescence microscopy 
can be a high background signal, generated either 
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intrinsically from cellular molecules or induced by the 
fixatives [37, 38]. This high background often precludes 
accurate analysis of immunostained pancreatic islets 
in FFPE tissue and is also enhanced by their high 
auto-fluorescence [39]. The interference from natural 
fluorescence relates to the tissue type and is due to the 
presence of endogenous molecules such as flavins, 
lipofuscins, reticulins, reduced NADP(H), collagen, 
elastin [37]. Pancreatic tissue has low accretion of flavins 
and lipofuscins [38], yet the fixatives used to preserve 
tissue morphology could increase signal background. 
FFPE samples are highly susceptible to this because of 
wax crystals and formaldehyde forming covalent bonds 
with adjacent amino-groups via through Schiff reactions. 
This can result in an intense fluorescent background with 
a typical emission between 450 and 650 nm [37, 38]. Here, 
we refined the de-waxing and hybridization conditions 
to decrease the background fluorescence and to enhance 
signal detection.
Of note, our modified deparaffinization/ 
hybridization protocol had no effect on either tissue 
morphology or the signal intensity at different wavelengths 
as shown, for example, by the strongly retained DAPI 
staining. 
Despite the labour-intensive pre-hybridisation 
protocol employed to ensure background signal reduction, 
the use of small contiguous RNA-labelled oligonucleotide 
probes offers several advantages when compared to 
either classical FISH (using long probes of >100nt) or 
indirect FISH that relies on intense signal amplification. 
Firstly, the strength of the bonds between the probe 
and the target is influenced by various factors such as 
formamide, salt concentration, temperature and pH. 
All these factors are easier to control for short than for 
long sequences. Secondly, systems which use branched 
probes for signal amplification may be more influenced 
by RNA degradation, because of the reduced freedom in 
positioning and flexibility that is allowed for the docking 
of two consecutive probes. 
Sensitivity and specificity of our probe set was 
tested on different virus strains as well as on various 
embedding procedures and was compared with indirect 
FISH on a set of previously analysed samples [25] as 
well as on newly prepared samples [30]. Our viral probes 
showed a sensitivity comparable to that of PCR analysis 
of cell lines when tested in infected cell lines.
Probe specificity was further tested in cell culture 
conditions and on a cell array [25]. We were able to 
successfully detect all the viruses with a probe-sequence 
homology of greater than 60%. From the alignment of our 
CVB_1 set probes with CVA5 and HPeV1, only 11/40 and 
0/40 oligos showed a perfect match and, as expected, these 
viruses were not detectable by our probe set.
As mentioned above, with the use of small 
contiguous RNA probes we were able to overcome the 
issue of RNA stability/degradation in samples, which had 
been stored over long periods of time. In particular, no 
signal loss occurred in samples processed at various points 
over a time course of 3 years. 
To test the utility of our probes in archive 
pancreatic tissue we undertook a blinded evaluation 
of T1D pancreata from a UK [40, 41] cohort, and 
expanded our CVB_1 probe set with the addition of 
2 complementary sets, namely CVB_2 and CVB_3. 
This broadened the opportunity to detect enteroviruses 
across the entire group B when used in combination. 
By this approach, we detected viral RNA in 7 of 8 T1D 
pancreata; 4 of which had also given positive signals using 
immunohistochemical analysis of VP1 expression.
Among the group of 7 RNA positive individuals, 6 
had viral RNA in insulin-containing cells whereas only 4 
were also immune-positive for VP1 (the parameter used 
to define “T1D VP1+” in this concordance study). The 
two pancreata, which were negative for viral RNA within 
islets using FISH probes were also immunonegative for 
enteroviral VP1. Typically, 1-2 islets per section showed 
viral genome staining but, unlike immunoreactive VP1, 
enteroviral RNA was not restricted solely to insulin 
positive cells.
Viral RNA was detected in two young non-diabetic 
control pancreata but at a much lower prevalence than 
among patients with T1D. Thus, enteroviral infection 
may not be absolutely unique to the islets of patients 
with T1D and it remains possible that cellular response 
to viral infection (rather than infection per se) is a critical 
determinant of autoimmunity.
In conclusion, we have developed a stringent and 
highly specific method for the detection of enteroviral 
genome in fixed pancreatic tissue with high sensitivity. 
We have used this method to confirm that viral RNA is 
detected in the pancreas in 7 of 8 patients with T1D and 
in only 2 of 8 controls. We propose that this new method 
may find wide applicability in future studies of the viral 
aetiology of type 1 diabetes.
MATERIALS AND METHODS
Cell culture and viruses
Human islets were isolated and cultured as 
previously described [42], HEK 293 and FHRK-4 
were cultured in Dulbecco’s Modified Eagle’s Medium 
(DMEM) at 5.5 mM glucose, CM9 and INS-1E in 
RPMI-1640 (Lonza) at 11.1 mM glucose. All media were 
supplemented with 1% penicillin/streptomycin and 10% 
fetal calf serum (FCS) or 1% FCS (FHRK-4). All cellular 
experiments were performed at 37°C and 5% CO2, if not 
stated otherwise. 
All viruses were propagated in FHRK-4 cells and 
purified in a sucrose gradient (40% sucrose, 10mM Tris pH 
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7,5, 100mM NaCl and 1mM EDTA), aliquots were stored 
at -80°C as previously described [43]. Cells were grown 
to confluency of 80-90% and infected with multiplicity of 
infection (MOI) of 5 supplemented growth media without 
FCS. Virus-containing media was replaced with 1% FCS 
fresh media after 2h of infection (post-infection). 
Probe design
Premade Stellaris® FISH Probes recognizing human 
GAPDH labeled with Quasar 570 (Catalog #SMF-2026-1-
BS) and custom Stellaris® FISH Probes, each recognizing 
various enteroviral strains, labeled with Quasar 570 were 
purchased from Biosearch Technologies, Inc. (Petaluma, 
CA). Briefly, the initial set of custom RNA FISH 
oligonucleotides (CVB_1) was designed on the CVB3 
consensus based sequence (M33854.1). The consensus 
sequence was generated from a ClustalW alignment of 
several coxsackieviruses to localize conserved regions, 
with thermodynamic characteristics fitted to the probe 
design [26]; in total, 50 regions of about 20 nucleotides 
(nts) in length with 2 nucleotides gap between adjacent 
regions and 45% GC content. Suitability of the regions 
for probe design were then verified using the Stellaris® 
RNA FISH Probe Designer (Biosearch Technologies, Inc., 
Petaluma, CA) available online at www.biosearchtech.
com/stellarisdesigner. As a result, 40 probes (Figure S4) 
distributed throughout the whole target genome were 
generated. For the CVB_2 and _3 probe sets design, 106 
genome sequences of viruses belonging to the enterovirus 
group B family were aligned (Figure S6) and divided into 
three subgroups based on sequence similarities. For each 
subgroup probes were designed based on newly generated 
consensus sequences as described before [26]. From the 
pool, 35 and 36 oligo probes were selected as CVB_2 and 
-3 pool for a sequential combinatorial approach to detect 
all the members of the enterovirus group B.
RNA FISH in FFPE tissue samples
The pre- and post-hybridization protocol for RNA 
fluorescent in situ hybridization (FISH) was modified 
based on the manufacturer’s instructions available online 
at www.biosearchtech.com/stellarisprotocols (version 
11.04.2013).
We adapted the pre-hybridization procedure by 
increasing the temperature of the xylene bath, in order to 
also access older FFPE tissue libraries [41]. The melting 
temperature for low-melting point paraffin is around 52°C 
and for normal paraffin is around 65-70°C [44, 45]. Melted 
paraffin can remain on the section forming wax crystals 
at lower temperatures (~57°C). Residual paraffin particles 
and wax crystals from the embedding procedure were 
removed by a series of Xylene washes (20 min at 70°C; 
10 min at 70°C; 10 min at room temperature), followed by 
rehydration in an ethanol (EtOH) gradient (100%, 100% 
and 95%) for 10 min each and for 1 h in 70% EtOH at 
room temperature. Finally, sections were rinsed twice with 
H2O for 1 min. All steps were performed with constant 
stirring.
Slides fixed with HgCl2 where washed with iodine 
to remove mercury, before the deparaffinization protocol. 
To facilitate probe annealing, sections were incubated 
for 20 min in 0.2M HCl (room temperature) and washed 
with 2x SSC Buffer (15 min, 70°C, slightly shaking) and 
PBS (2x 1 min, room temperature). Pepsin (Sigma) was 
applied and washed off after 10 min incubation at 37°C 
with PBS (2 times 1 min, room temperature). To quench 
any remaining autofluorescence of biological molecules 
0.5-1% Sudan Black (Sigma-Aldrich) in 70% EtOH was 
added for 20 min (room temperature) and thoroughly 
washed off with PBS (3x times 5 min, room temperature). 
Tissues were equilibrated with washing buffer (10% 
formamide, 2xSSC, 2x, 5 min at room temperature) before 
hybridization. Stellaris® FISH Probes (GAPDH 0,125 µM; 
viral RNA 0,25 µM) were diluted in hybridization buffer 
(10% w/v Dextran sulfate, 10% formamide, 2xSSC) and 
samples incubated overnight at 37°C in a humidified 
chamber. Hybridization mix was aspirated and sections 
were washed extensively. Stringency was increased 
with each washing step to remove any unspecific probe 
binding, thus reducing background noise and increasing 
relative signal intensity. Slides were washed at 37°C with 
constant agitation; twice with 2xSSC and 10% formamide 
for 20 min, twice with 2xSSC for 15 min, twice with 
1xSSC for 15 min, once with 0.1x SCC for 15 min and 5 
min. VECTASHIELD® antifade mounting medium (Vector 
laboratories) including 4’,6-Diamindino-2-phenylindole 
(DAPI) was immediately added and images were acquired 
with a Nikon Ti MEA53200 (NIKON GmbH, Düsseldorf, 
Germany) microscope. A 60x oil-immersion objective 
(N.A. 1,4). TRITC filter (ex. 520- 560nm) was used to 
acquire images of the Quasar 570 labeled probes. Control 
images were always taken with the FITC filter (ex. 465- 
495nm) at the same exposure time to ensure no false-
positive signals caused by a bleed-through from one 
channel to another. NIS-Elements BR (NIKON GmbH, 
Düsseldorf, Germany) and ImageJ (NIH, USA) were used 
for image analysis. 
RNA FISH in cell lines
Cells were cultivated on 13x13 mm #1 microscope 
cover glasses (Marienfeld GmbH & Co. KG, Lauda-
Königshofen, Germany) in 24-well plates to a confluency 
of 80-90% and treated as indicated. Further processing 
followed manufacturer’s instructions available online at 
www.biosearchtech.com/stellarisprotocols (11.04.2013). 
Briefly, cover glasses were rinsed with PBS and cells were 
fixed (3,7% formaldehyde, 1x PBS) for 10 min at room 
temperature, followed by two washes with PBS (room 
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temperature). To permeabilize the cellular membrane 70% 
EtOH was added for overnight incubation at 4°C. EtOH 
was removed, cells were equilibrated with washing Buffer 
(5 min, room temperature) and respective RNA FISH 
probe mix was added for overnight hybridization at 37°C 
in a humidified chamber. Hybridization mix was aspirated; 
cells were washed twice with washing buffer (20 min, 
37°C) and rinsed with 2xSSC (room temperature). Cover 
glasses were placed on glass slides with VECTASHIELD® 
antifade mounting medium (Vector laboratories) including 
DAPI and analyzed as described above.
Immunohistochemistry
FFPE sections were deparaffinized as described 
above. Antigen retrieval was performed in heated 
unmasking solution (Vector laboratories) in three 
consecutive 5 min microwave cycles (full power). Sections 
were blocked (TBS, 3% BSA IgG free, 0.2% Tween) for 
1h at room temperature and primary anti-VP1 (DAKO, 
clone 5-D8/1, dilution 1/2000) was applied for over night 
incubation at 4°C. FITC anti-mouse (1/100) for 1h at room 
temperature was used as secondary antibody. 
Co-immunostaining of insulin and RNA-FISH
Samples were first probed for RNA targets and 
analyzed as described above. Afterwards, the coverslip 
was gently removed, slides were immersed in washing 
buffer and anti-insulin (DAKO) was applied for 
overnight incubation at 4°C. Sections were washed three 
times with washing buffer (5 min, room temperature), 
incubated for 1h at room temperature with fluorescein 
isothiocyanate (FITC) anti-guinea pig, were washed 3x 
with 2xSSC (5 min, room temperature) and mounted with 
VECTASHIELD® antifade mounting medium (Vector 
laboratories) including DAPI.
Co-immunostaining of VP1 and RNA-FISH
Cells were infected with CVB3 (MOI 1000) for 
1h (16°C). Media was changed and temperature shifted 
to 37°C. Cells were fixed 30 min post-infection using a 
solution of 3,7% formaldehyde in 1x PBS for 10 min. 
Cells were permeabilized with 70% EtOH overnight at 
4°C and probed with RNA probes as described above. 
Cells were washed and stained for VP1 (1/2000; 1h; RT) 
and FITC anti-mouse as secondary antibody. 
RNA isolation, reverse transcription and real time 
PCR
RNA was extracted using Trizol® reagent 
(Invitrogen, Darmstadt, Germany) according to 
manufacturer’s protocol. Extracted RNA was treated with 
DNAse I (Ferments Life Science, Waltham, MA, USA) 
and reverse transcribed with ReverseAid kit (Fermentas) 
according to manufacturer’s instructions. Real time PCRs 
reactions were prepared according to Applied Biosystems 
guidelines using SybrGreen assay and performed in a 
StepOnePlus instrument (Applied Biosystems, Carlsbad, 
CA, USA). PCR efficiencies were monitored for each 
sample according to a previously described approach [46]. 
Results are presented as relative quantification. SybrGreen 
Primers used: 
CVB fw 5’ GGCCCCTGAATGCGGCTAAT 3’,
CVB rev 5’ TGGCTGCTTATGGTGACAATTG 3’; 
Microglobulin β2 fw 5 
́TTTACTCACGTCATCCAGCAG A 3’; 
Microglobulin β2 rev 5 
́CGGCAGGCATACTCATCTTT 3’. 
RNAse treatment
CVB3 infected FFPE human islets sections were 
prepared as described above. To digest any viral or 
endogenous RNA 100µg/ml RNAse A (Macherey-Nagel) 
in 2xSSC buffer or 2xSSC Buffer alone was applied to the 
sections for 1h at 37°C. At this salt-concentration (150mM 
NaCl) single-stranded, as well as double-stranded RNA, is 
enzymatically cleaved by RNase A [47]. 
Viral dilution and FISH analysis
CVB 3 was diluted in RPMI-1640 media in 
logarithmic steps, starting from 102 (MOI 100) to 10^-8. 
Infection media was added to respective cells in a 24-well 
plate either grown on coverslips or without. Cells were 
directly transferred to a tabletop centrifuge and spun for 
1h at 16°C and 105 rcf., followed by 1.5h (HEK 293) 
or 3h (CM9) post-infection at 37°C. Afterwards one set 
of cells was used for RNA isolation and the other for 
microscopical analysis. Ten images were acquired for each 
condition, choosing the same areas of the slide for every 
dilution. 
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